ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

BCDA BioCardia Inc

0.3766
0.0086 (2.34%)
After Hours
Last Updated: 16:30:00
Delayed by 15 minutes

Period:

Draw Mode:

Volume 29,240
Bid Price 0.3525
Ask Price 0.3898
News -
Day High 0.384

Low
0.32

52 Week Range

High
2.9199

Day Low 0.369
Company Name Stock Ticker Symbol Market Type
BioCardia Inc BCDA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0086 2.34% 0.3766 16:30:00
Open Price Low Price High Price Close Price Prev Close
0.373 0.369 0.384 0.3766 0.368
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
117 29,240 $ 0.3763849 $ 11,005 - 0.32 - 2.9199
Last Trade Time Type Quantity Stock Price Currency
16:00:00 105 $ 0.3766 USD

BioCardia Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
8M 21.62M - 477k -11.57M -0.54 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

BioCardia News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No BCDA Message Board. Create One! See More Posts on BCDA Message Board See More Message Board Posts

Historical BCDA Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.370.3850.320.369822275,9230.00661.78%
1 Month0.420.420.320.382652687,009-0.0434-10.33%
3 Months0.4350.590.320.4268102350,787-0.0584-13.43%
6 Months0.38781.550.320.94246631,493,138-0.0112-2.89%
1 Year1.982.91990.320.9472391799,034-1.60-80.98%
3 Years3.875.09880.321.49475,703-3.49-90.27%
5 Years5.248.600.323.07529,105-4.86-92.81%

BioCardia Description

BioCardia Inc is a clinical stage regenerative medicine company. It is developing therapeutics for cardiovascular diseases with large unmet medical needs. The company is developing comprehensive biotherapeutic candidates for cardiac regenerative medicine namely CardiAMP and CardiALLO, with a focus on heart failure resulting from a heart attack.

Your Recent History

Delayed Upgrade Clock